Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0211Source: DataRank Database

Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0.725. It has been cited 125 times.

N/A

0.725DataRank · unranked

Scored on demand from live citation data

Open Access125 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenLinked Datasets (18)DataCite Reuse (18)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.725

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (19)

Caroline J. Bull ORCID,Clementina Mesaros ORCID,Jennifer M. Finan ORCID,Madeleine Carens,Elaine S. Ho ORCID

Live enrichment

PubMed:30945415

National Institutes of Health

Grant: P01CA104838

Foundation for the National Institutes of Health

Grant: R35CA197602

Damon Runyon Cancer Research Foundation

Grant: DRG2326-18

Diabetes UK

Grant: 17/0005587

National Institute of Environmental Health Sciences

Grant: P30ES013508

World Cancer Research Fund International

Grant: IIG_2019_2009

greenLicense: other-oa

repositoryhttps://research-information.bris.ac.uk/en/publications/724e4afc-209e-46ad-abad-8dd4d2a65345

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/11/12/3106/3282122/3106.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8741905

repositoryhttps://hdl.handle.net/1983/724e4afc-209e-46ad-abad-8dd4d2a65345

Additional file 1 of HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma

10.6084/m9.figshare.25052259.v1figshare

Additional file 1 of HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma

10.6084/m9.figshare.25052259figshare

Additional file 2 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563950.v1figshare

Additional file 2 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563950figshare

Additional file 3 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563953.v1figshare

Additional file 3 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563953figshare

Additional file 4 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563956.v1figshare

Additional file 4 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563956figshare

Additional file 5 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563959.v1figshare

Additional file 5 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563959figshare

Additional file 6 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563962.v1figshare

Additional file 6 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563962figshare

Additional file 7 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563965.v1figshare

Additional file 7 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563965figshare

Additional file 2 of HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma

10.6084/m9.figshare.25052467figshare

Additional file 2 of HIF-2α/LINC02609/APOL1-mediated lipid storage promotes endoplasmic reticulum homeostasis and regulates tumor progression in clear-cell renal cell carcinoma

10.6084/m9.figshare.25052467.v1figshare

Additional file 1 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563947.v1figshare

Additional file 1 of TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability

10.6084/m9.figshare.26563947figshare